# Detection of Breast Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC

> **NCT03480659** · — · TERMINATED · sponsor: **HKGepitherapeutics** · enrollment: 165 (actual)

## Conditions studied

- Breast Cancer
- Breast Cancer Female

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03480659
- **Lead sponsor:** HKGepitherapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-06-01
- **Primary completion:** 2021-08-01
- **Final completion:** 2021-09-01
- **Target enrollment:** 165 (ACTUAL)
- **Why stopped:** Experienced technical issues with plasma blood samples collected from patients.
- **Last updated:** 2023-12-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03480659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03480659, "Detection of Breast Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03480659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*